Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Tables)

v3.10.0.1
Net Loss per Share (Tables)
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics, Inc. and Subsidiaries for the three and nine months ended September 30, 2018 and 2017
(in thousands except share and per share amounts)
:
 
 
 
Three months ended September 30, 2018
 
 
Nine months ended September 30, 2018
 
 
 
Net loss

(Numerator)
 
 
Shares

(Denominator)
 
 
Per Share

Amount
 
 
Net Loss

(Numerator)
 
 
Shares

(Denominator)
 
 
Per Share

Amount
 
Net loss - Basic
 
$
(3,741
)
 
 
4,028,304
 
 
$
(0.93
)
 
$
(10,375
)
 
 
3,802,812
 
 
$
(2.73
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(4,214
)
 
 
4,028,304
 
 
$
(0.93
)
 
$
(10,375
)
 
 
3,802,812
 
 
$
(2.73
)
  
 
 
Three months ended September 30, 2017
 
 
Nine months ended September 30, 2017
 
 
 
Net loss

(Numerator)
 
 
Shares

(Denominator)
 
 
Per Share

Amount
 
 
Net Loss

(Numerator)
 
 
Shares

(Denominator)
 
 
Per Share

Amount
 
Net loss - Basic
 
$
(17,823
)
 
 
3,665,134
 
 
$
(4.90
)
 
$
(24,925
)
 
 
3,512,868
 
 
$
(7.00
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(17,823
)
 
 
3,665,134
 
 
$
(4.90
)
 
$
(24,925
)
 
 
3,512,868
 
 
$
(7.00
)